Divergent Whole-Genome Methylation Maps of Human and Chimpanzee Brains Reveal Epigenetic Basis of Human Regulatory Evolution  by Zeng, Jia et al.
ARTICLE
Divergent Whole-Genome Methylation Maps
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and Soojin V. Yi1,*
DNAmethylation is a pervasive epigenetic DNAmodification that strongly affects chromatin regulation and gene expression. To date, it
remains largely unknown how patterns of DNA methylation differ between closely related species and whether such differences
contribute to species-specific phenotypes. To investigate these questions, we generated nucleotide-resolution whole-genome methyla-
tion maps of the prefrontal cortex of multiple humans and chimpanzees. Levels and patterns of DNA methylation vary across individ-
uals within species according to the age and the sex of the individuals. We also found extensive species-level divergence in patterns of
DNAmethylation and that hundreds of genes exhibit significantly lower levels of promoter methylation in the human brain than in the
chimpanzee brain. Furthermore, we investigated the functional consequences of methylation differences in humans and chimpanzees
by integrating data on gene expression generated with next-generation sequencing methods, and we found a strong relationship
between differential methylation and gene expression. Finally, we found that differentially methylated genes are strikingly enriched
with loci associated with neurological disorders, psychological disorders, and cancers. Our results demonstrate that differential DNA
methylation might be an important molecular mechanism driving gene-expression divergence between human and chimpanzee brains
and might potentially contribute to the evolution of disease vulnerabilities. Thus, comparative studies of humans and chimpanzees
stand to identify key epigenomic modifications underlying the evolution of human-specific traits.Introduction
DNA methylation is a crucial epigenetic modification of
genomic DNA found inmany taxa. Studies onmammalian
model organisms have established several critical func-
tional roles of DNAmethylation. In the human andmouse
genomes, DNA methylation is involved in developmental
and regulatory processes, such as genomic imprinting,
X chromosome inactivation, chromatin compaction, and
transcriptional silencing.1 Impairment of DNA-methyla-
tion patterns results in devastating phenotypic conse-
quences: the knockout of enzymes responsible for DNA
methylation results in embryonic lethality in mice.2,3 In
humans, aberrant DNA methylation is implicated in
several neurodevelopmental syndromes and cancers.4,5
DNA methylation is also phylogenetically widespread. In
particular, although some animal taxa lack DNA methyla-
tion (most notably the model invertebrates Drosophila
melanogaster and Caenorhabditis elegans), emerging genome
projects have increasingly demonstrated the conservation
of basic DNA-methylationmachineries and the presence of
DNA methylation in diverse animal lineages.6–9 Moreover,
comparative studies of DNA methylation show that some
targets of DNA methylation are conserved over extraordi-
narily long evolutionary timescales, indicating potentially
conserved evolutionary roles of DNA methylation in
different genomes.101School of Biology, Georgia Institute of Technology, Atlanta, GA 30332, USA;
Departments of Neurology, and Human Genetics, David Geffen School of Me
3Department of Neuroscience, University of Texas Southwestern Medical Cent
Diseases, Yerkes National Primate Research Center, Emory University, Atlant
University, Atlanta, GA 30329, USA; 6Department of Pathology and Laborator
*Correspondence: soojinyi@gatech.edu
http://dx.doi.org/10.1016/j.ajhg.2012.07.024. 2012 by The American Societ
The AmericanDespite its functional importance and the widespread
conservation of some of its features, recent studies of
detailed DNA-methylation maps have begun to reveal
important phyletic variations in genomic DNA methyla-
tion as well.11,12 For example, vertebrate and invertebrate
genomes exhibit dramatic differences in the genomic
distribution and levels of DNA methylation, as well as
the functional roles of DNA methylation.11–13
An important and presently unanswered question is
how patterns of DNA methylation differ between closely
related species and whether such differences contribute
to the evolution of species-specific phenotypes. It has
long been hypothesized that regulatory evolution (evolu-
tion of gene expression), rather than evolution of
protein-coding sequences, is the major evolutionary force
underlying divergence of species.14,15 However, eluci-
dating the nature of molecular mechanisms underlying
regulatory evolution has been a challenge. DNA methyla-
tion is well known to affect regulation of gene expression
on several fronts, the most well known of which is the
link between promoter methylation and silencing of tran-
scription.1 DNA methylation is also implicated in other
aspects of regulation, including transcript composi-
tion.16,17 Given the significance of DNA methylation for
the regulation of gene expression, we hypothesize that
DNA methylation serves as an important determinant of
regulatory evolution underlying species divergence.2Program in Neurogenetics, Semel Institute and Department of Psychiatry,
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To explore this hypothesis, we investigate here the
differences in nucleotide-resolution, genome-wide meth-
ylation maps of the prefrontal cortex of multiple humans
and chimpanzees by using the whole-genome sequencing
of bisulfite-converted DNA (‘‘methyl-C-seq’’). The methyl-
C-seq method represents a vast improvement from
previous methods that are low resolution (such as high-
performance liquid chromatography [HPLC]) or that focus
on specific genomic regions, such as CpG islands, (e.g.,
array-based methods or enrichments) because it provides
an unbiased, comprehensive, and highest-resolution map
of genome-wide DNA methylation.18–21 This method is
also a superior choice for comparative studies for several
reasons; for example, using methylation arrays designed
for the human genome is potentially problematic when
applied to other species because of the divergence of
underlying genomic sequences. In comparison, the
methyl-C-seq method does not depend on underlying
sequences, thus making it ideal to be used in comparisons
of genome-wide patterns of DNA methylation between
species. In addition, because the methyl-C-seq approach
enables the methylation frequency of each cytosine to
be estimated independently, we can evaluate global
differences between methylation maps of different tissues
and species.
Indeed, using the methyl-C-seq method, we discovered
several significant patterns in the brain methylation
maps, and we infer potential global-level differences
between the brain DNA-methylation maps of humans
and chimpanzees. Integrating data on DNA methylation
with newly generated data on gene expression, we show
that changes in DNA methylation at least partially explain
the divergence of gene-expression patterns in human and
chimpanzee brains. Furthermore, differentially methyl-
ated genes show striking associations with specific neuro-
logical and psychological disorders and cancers, suggesting
that changes of DNA methylation might be linked to the
evolution of human-specific disease vulnerabilities.Materials and Methods
Generating Methyl-C-Seq Libraries
Regions of prefrontal cortex were dissected out of postmortem
brains of three humans (Homo sapiens) and three chimpanzees
(Pan troglodytes) (Table S1, available online). Chimpanzee samples
came from animals that died of natural causes or were euthanized
for humane reasons at the Yerkes National Primate Research
Center, and all procedures involving these animals conformed to
guidelines established by the Yerkes Institutional Animal Care
and Use Committee. Human brain samples were obtained from
the Maryland Brain and Tissue Bank from individuals who died
of causes unrelated to neurological disorders.
Methyl-C-seq libraries for Illumina sequencing were custom
constructed (Alpha Biolaboratory, Burlingame, CA) according to
Lister et al.21 with minor modifications. In brief, ~1 mg of genomic
DNA was fragmented by sonication, end repaired, and ligated to
custom-synthesized methylated adapters (Eurofins MWGOperon,
Huntsville, AL) according to the manufacturer’s (Illumina, San456 The American Journal of Human Genetics 91, 455–465, SeptembDiego, CA) instructions. Adaptor-ligated libraries were subjected
to two successive treatments of sodium bisulfite conversion with
the EpiTect Bisulfite kit (QIAGEN, Valencia, CA) as outlined in
the manufacturer’s instructions. Five to ten nanograms of
bisulfite-converted libraries was PCR amplified with the following
condition: 2.5 U of ExTaq DNA polymerase (Takara), 5 ml of 10X
Extaq reaction buffer, 25 mM dNTPs, 1 ml Primer 1.1, and 1 ml
Primer 2.1 (50 ml final). The thermocyling was as follows: 95C
for 3 min and then 14–16 cycles each of 95C for 30 s, 65C
for 30 s, and 72C for 60 s. The enriched libraries were purified
twice with the solid-phase reversible immobilization (SPRI)
method with AMPure beads (Beckman Coulter, Brea, CA). We
assessed the library quality by randomly subcloning and
sequencing ~20–30 colonies to check for proper library construc-
tion and bisulfite conversion. The quality-controlled bisulfite-
converted methyl-C-Seq libraries were then sequenced at the UC
Berkeley Genome Center and Emory Genome Sequencing Labora-
tory with the Illumina Genome Analyzer II and the Illumina
Hi-Seq, respectively. After quality control, the reads per lane
ranged between 15 and 70 million reads. The average phred
quality score for each read was 37.Mapping and Annotation
We first converted all C’s to T’s both in the reads and in the refer-
ence genomes, and we then aligned the converted reads to the
converted reference genomes by using the Bowtie algorithm.22
The assembly versions of the reference genome we used for
mapping are GRCh37/HG19 for humans and CGSC2.1/panTro2
for chimpanzees. Total mapped reads accounted for 1.03 3 1011
(humans) and 9.80 3 1010 (chimpanzees) nucleotides, providing
34.33 and 32.63 species-level coverages for human and chim-
panzee haploid genomes, respectively.
For comparative analyses of human and chimpanzee methyla-
tion profiles, we utilized the data sets from the Chimpanzee
Sequencing and Analysis Consortium,23 consisting of 13,454
human-chimpanzee orthologous gene pairs. The orthology of
these gene alignments was considered unambiguous and covered
the whole coding region. On the basis of these ortholog RefSeq
gene IDs, we downloaded the genomic coordinates from the
UCSC genome browser. Promoters were defined as regions 1.5 kb
upstream and 0.5 kb downstream of the transcription start sites.
Gene bodies were defined as those encompassing the region
from the transcription start site to the transcription end site. Gene-
Trail24 and the DAVID tools25 were used for the functional anno-
tation enrichment and disease association tests.Identification ofMethylated Cytosines Accounting for
False-Positive Rates
We estimated the error rate (nonconversion rate plus sequencing-
error frequency), p, from the number of cytosine bases sequenced
in reference cytosine positions in the unmethylated Lambda
genome. Error rates estimated from these were between 0.0013
and 0.0017. We controlled the number of false-positive methylcy-
tosine calls below 0.1% of the total number of methylcytosines as
follows: the minimum threshold number of cytosines sequenced
at each reference cytosine position at which the position could
be called as methylated is equal to (n 3 p) / (a(1  p) þ p), where
n is the read depth for that site, p is the error rate, and a is a prede-
fined false-discovery value (0.001 for our case).
Levels of DNA methylation were calculated by two methods.
First, in a false-discovery rate (FDR) method, each referenceer 7, 2012
cytosine was examined and labeled as methylated or unmethy-
lated according to the criterion that the number of false-positive
methylcytosine calls should be below 0.1% (see above). In the
secondmethod, we calculated the ‘‘fractional methylation’’ values
of each cytosine;12,21 these values are defined as the total number
of ‘‘C’’ reads / (total number of ‘‘C’’ reads þ total number of ‘‘T’’
reads). Results from these two methods were highly similar, and
the results from the latter method are shown in the main text
unless otherwise specified. We discarded those sites with read
depths of less than 3. Results from before or after duplicates
were removed with the Rmdup tool in the Samtools package26
were highly similar.Digital Gene-Expression Profiling Data
Frozen tissue samples from postmortem brains of six humans and
six chimpanzees were used (Table S2). Human and chimpanzee
individuals died of causes unrelated to neurological disorders.
Samples were dissected either from fresh tissue at the time of brain
procurement or later on dry ice from frozen tissue pieces from the
prefrontal cortex region of the frontal pole. Total RNA was ex-
tracted with QIAGEN’s RNeasy or miRNeasy kits according to
the manufacturer’s instructions. All RNA samples were examined
for quantity and quality by NanoDrop and Bioanalyzer (Agilent).
Sequencing libraries were generated from DpnII-digested poly-A
enriched RNA according to the manufacturer’s (Illumina) instruc-
tions. BFAST27 was used for aligning 20 bp reads to both the
genome and RefSeq of the respective species. We allowed up to
one mismatch with the reference genome in any location within
the read. Only reads that aligned to one location in the genome
were used for analysis. Alignments to multiple isoforms of
a gene were collapsed across gene symbol, and the maximum
number of reads for a given isoform was used. A gene was consid-
ered ‘‘present’’ if every individual of a species for a given brain
region had at least two reads aligned to the gene. For differential
expression analysis, a gene had to be present in at least one of
the species being compared. Reads were normalized with quantile
normalization.
To examine whether there were any underlying batch effects in
our data, we processed all samples from both species together.
Analysis of variance28 of sample traits via univariate linear regres-
sion analysis with the first principal component as outcome re-
vealed that species was the most significant sample covariate
and was followed by individual and then age. Technical variation
sources, including postmortem interval, RNA batch, run batch,
and library batch, were not significant, similar to a previous
study.29 Statistical significance of differentially expressed genes
was determined with a Bayesian t test.30 We also performed
a two-sample permutation test between human and chimpanzee
expression values and compared it to the p value from our original
method. At the 5% significance level, approximately 92% of genes
showed a concordant pattern between these two methods. For the
inconsistent genes, most were significant from the permutation
test and weakly significant from our original method.Comparative Human Methylome Analysis among
Different Tissues
We compared the human prefrontal cortex (brain) methylome
that had the highest mean read depth and lowest duplicate read
count (Hs1570) tomethylomes generated from human embryonic
stem cells (ESCs),18 human neonatal foreskin fibroblasts,18 and
human peripheral-blood mononuclear cells (PBMCs).19 Methyla-The Americantion data from other tissues and cell lines were obtained from
respective publications. In brief, the ESCs were derived from
aWA09 hESC line,31 were cultured feeder free on Matrigel (Becton
Dickinson) in StemPromedium (Lifetech), and were passaged with
Accutase (Lifetech). The neonatal fibroblast cell lines were ob-
tained from GlobalStem (newborn human foreskin fibroblasts,
untreated) and were harvested for analysis at passage 13. The
human PBMCs were obtained from the same individual as in the
YanHuang project, which is the first finished diploid genome
sequence of an Asian individual.19
Methylome data on ESCs, neonatal fibroblasts, and PBMCs were
downloaded from the Gene Expression Omnibus, and coordinates
were converted from human genome build hg18 to hg19 with the
UCSC liftover tool. Bisulfite-converted sequence data were merged
for all CG dinucleotides and CH dinucleotides (H¼ A, C, or T) that
had at least three strand-specific reads in each of the four methyl-
omes being compared. Mean fractional methylation of annotated
elements was calculated as the mean of fractional methylation
values for each site within the annotated element.Results
Genome-wide DNA-Methylation Patterns Reveal
Extremely Heavily Methylated Brains
We generated whole-genome, nucleotide-resolution DNA-
methylation maps (methylomes) from prefrontal cortex
samples of three humans and three chimpanzees by
sequencing bisulfite-converted genomic DNA (Materials
and Methods and Table S1). Bisulfite conversion rates
estimated from unmethylated lambda DNA controls indi-
cate that our method faithfully captures patterns of
genomic DNA methylation in these samples (Materials
and Methods).
Prefrontal cortex methylation maps from both species
reveal extremely heavy CpG methylation—between
79.4% and 82.5% of CpGs are methylated. In comparison,
only minor fractions of non-CpG sites (1.3%–2.2%) are
methylated (Figure 1). Consistent with other tissues and
species,11,12,21 DNA-methylation levels across transcrip-
tion units in the prefrontal cortex exhibit distinctive
patterns: there are low methylation levels in DNA
surrounding the transcription start site, higher levels along
the transcribed unit (gene body), and decreased levels near
the transcription termination site (Figure S1). Among
genomic regions, promoters and CpG islands are generally
hypomethylated (Figure 1 and Figures S2 and S3). Trans-
posable elements are the most heavily methylated in
both species (Figure 1C), supporting the idea that DNA
methylation suppresses proliferation of transposons in
these genomes.32
To gauge tissue-specific differences in levels of DNA
methylation, we compared the methylation maps of the
human prefrontal cortex to those from three other tissues,
including ESCs, neonatal fibroblasts, and PBMCs (Figure 1).
These methylomes were generated with similar methods,
facilitating a direct comparison of overall levels of DNA
methylation among tissues.18,19 Our analysis reveals that
the prefrontal cortex is the most heavily methylated ofJournal of Human Genetics 91, 455–465, September 7, 2012 457
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Figure 1. Differences in DNA-Methylation Levels among Human Tissues and Genomic Features
(A) Proportional representation of genome-wide DNA-methylation levels for individual CG dinucleotides in the human prefrontal
cortex (brain), ESCs,18 neonatal fibroblasts,18 and PBMCs.19
(B) Same analyses as in (A) but for CH dinucleotide context (H ¼ A, T, or C).
(C) Mean methylation levels in each tissue for gene promoters (CG context, n ¼ 18,416; CH context, n ¼ 18,584), gene bodies (CG
context, n ¼ 18,477; CH context, n ¼ 18,656), and transposable elements (CG context, n ¼ 1,837,431; CH context, n ¼ 2,989,765).
Horizontal lines indicate global means of methylation levels for individual CG sites (main panel) or CH sites (inset). Error bars indicate
95% confidence intervals of the mean.these four tissues (Figure 1). A high level of methylation in
the prefrontal cortex is consistent throughout different
genomic regions and across different cytosine classes
(Figure 1 and Figures S4 and S5).
Interspecies and Intraspecies Variation of
Genome-wide Patterns of DNA Methylation
Genome-wide brain methylation maps of humans and
chimpanzees exhibit intriguing intraspecies and interspe-
cies variations (Figure 2). In terms of intraspecies variation,
we found that the prefrontal cortex samples from younger
individuals exhibit generally higher levels of DNAmethyl-
ation in both species (Figure 2C and 2D). For example, the
chimpanzee individuals are 24, 27, and 43 years of age. At
the genome-wide level, the third (43-year-old) individual
exhibits slightly but significantly lower methylation
than the other individuals. In human samples, a younger
(31-year-old) individual is overall more heavily methylated
than the other two individuals of ages 47 and 48 years.
However, given the small sample size, these results should458 The American Journal of Human Genetics 91, 455–465, Septembbe taken with caution and need to be validated in a study
with a larger number of individuals spanning greater vari-
ation of ages. Furthermore, the within-species variation of
methylation is also confounded by the methylation differ-
ence between genders. It has been demonstrated that
methylation levels on the X chromosome exhibit a signifi-
cant gender effect.33 We observed similar results (Figure S6
and S7). However, our results do not change when data
from the X chromosome are excluded (Figure S8 and S9).
Despite the substantial intraspecies variation of DNA
methylation, we detected interesting divergence between
the human and chimpanzee prefrontal methylation
maps. Principal-component analyses of DNA-methylation
levels of promoters and gene bodies of human-chimpanzee
orthologs demonstrate that major principal components
separate humans and chimpanzees (Figures 2A and 2B).
A previous study reported that human brains are more
heavily methylated than chimpanzee brains on the basis
of a limited number of CpG dinucleotides (145 CpGs
from 36 genes).34 Our data do not support this findinger 7, 2012
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Figure 2. Between- and Within-Species
Variation of Genomic DNA Methylation
in Human and Chimpanzee Prefrontal
Cortex Regions
Principal-component analyses of (A)
promoters and (B) gene bodies of human-
chimpanzee orthologs23 demonstrate that
the patterns of DNA methylation are
distinct between humans and chimpan-
zees. For promoters, the first principal
component, which explains 46.1% of vari-
ation, distinguishes samples from human
and chimpanzees. The second principal
component, explaining 27.7% of total
variation, separates two human samples
from the third one. For gene bodies, the
first principal component (explaining
42.8% of total variation) separates the
third human from the rest, whereas the
second principal component (explaining
22.6% of total variation) separates the
human and chimpanzee brains. Hierar-
chical clustering analyses of (C) promoters
and (D) gene bodies demonstrate that the
overall levels of methylation are lower in
human brains than in the chimpanzee
brains. The youngest human individual
(H3) exhibits the most distinctive pattern
of DNA methylation. The error bars indi-
cate 95% confidence intervals of the mean.(Figures 2C and 2D). In our data, there is higher methyla-
tion in the chimpanzee brains than in the human brains
(the average fractional methylation levels of CpG dinucle-
otides in the human and chimpanzee genomes are 80.9%
(50.036% standard error [SE]) and 82.1% (50.034% SE),
respectively (Mann-Whitney test, p < 1015). An analysis
of the specific CpG sites included in the previous study34
revealed no difference between the two species in our
data (Table S3). The difference might in part be due to
the fact that the previous study used a low-resolution
methylation array developed specifically for the human
genome.34
Distinctive Patterns of Promoter Methylation,
Functional Enrichment, and Disease Association
Previous studies determined that DNA methylation in
vertebrate promoters occurs in a discrete fashion—these
promoters can be classified as hypermethylated and
hypomethylated.35,36 In accordance with these studies,
promoter DNA methylation in human and chimpanzee
brains falls into distinct hypermethylated and hypomethy-
lated classes (Figure 3A). In comparison, gene bodies are
generally heavily methylated in the prefrontal cortex of
both species (Figure 3B), which is expected under ‘‘global’’
patterns of genomic DNA methylation.13,35 Levels of DNAThe American Journal of Human Genmethylation in promoters and gene
bodies are clearly lower in the human
brain than in the chimpanzee brain
(Figure 3A and 3B), a difference that
is especially marked for promoters(Figures 3A and 3C and Figure S2), which on average
exhibit 23% less methylation in humans than in chimpan-
zees (Figure S2).
To identify significantly differentially methylated pro-
moters between human and chimpanzee brains, we per-
formed the following tests. First, we performed a Fisher’s
exact test by using the total numbers of methylated and
unmethylated CpG sites in all samples and calculated
adjusted p values by the FDR method for multiple
testing.37,38 Then, from the pool of significantly differen-
tially methylated promoters obtained by this test, we
further classified genes into those with hypermethylated
(defined as fractional methylation levels> 0.8) or hypome-
thylated (fractional methylation levels < 0.2) pro-
moters35,36 (Figure 3). From these gene sets, we identified
474 genes whose promoters had ‘‘switched’’ between the
hypermethylated and hypomethylated classes between
the human and chimpanzee brains. In the majority
(n ¼ 468) of these promoters, human brains exhibit
conspicuously lower levels of DNA methylation than do
chimpanzee brains (Table S4). Interestingly, these genes
are significantly enriched in molecular functions such as
protein binding and phosphotransferase activity (Table 1).
Moreover, they exhibit striking associations with several
disorders, including neurological and psychologicaletics 91, 455–465, September 7, 2012 459
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Figure 3. Patterns of DNA Methylation in Genic Regions Influ-
ence Gene Expression
Density plots of (A) promoter and (B) gene-bodyDNAmethylation
from humans and chimpanzees. Promoter DNA methylation
exhibits distinctive ‘‘bimodal’’ patterns previously observed.35,36
In comparison, gene bodies of both species are heavily methylated
(B). DNA-methylation-level differences, measured as the mean of
human methylation levels minus the mean of chimpanzee meth-
ylation levels, show that promoters particularly exhibit lower
levels of DNA methylation in the human brain than in the chim-
panzee brain (C). In contrast, gene bodies show similar levels of
DNA methylation between species (D).
Table 1. Genes Whose Promoters Are Hypomethylated in the
Human Brain but Hypermethylated in the Chimpanzee Brain Are
Enriched in Specific Gene Ontology Terms
GO Terms
GO Accession
Number p Value (FDR)
Cellular process GO:0009987 7.2 3 105
Protein binding GO:0005515 1.8 3 104
Cellular macromolecule
metabolic process
GO:0044260 1.9 3 103
Cellular metabolic process GO:0044237 4.3 3 103
Transferase activity,
transferring phosphorus-
containing groups
GO:0016772 1.0 3 102
The number of genes analyzed is 468. The following abbreviations are used:
GO, Gene Ontology; and FDR, false-discovery rate.disorders and cancers. For example, genes whose variants
are associated with autism are 3.5-fold enriched in this
group of genes (although not significantly so because of
the small number of genes [Table 2]). The six genes exhib-
iting hypermethylation of human promoters compared to
the chimpanzee promoters also include several genes
whose variants are linked to disease (Table S5).
The above-described method for identifying differen-
tially methylated promoters is perhaps overly stringent.
Thus, we developed a secondmethod, based on the relative
difference in promoter methylation, to identify differen-
tially methylated promoters. Beginning with genes for
which Fisher’s exact test with the FDR method was signifi-
cant, we first defined genes whose relative methylation
levels had changed more than 50%; in other words, genes
for which j(chimp fractional methylation level  human
fractional methylation level)/(chimp fractional methyla-
tion levelþ human fractional methylation level)j is greater
than 0.5. We further restricted analysis to genes for which
the absolute difference between the fractional methylation
levels of humans and chimpanzees is greater than 0.2.
Using this method, we identified 1,055 genes that are
significantly less methylated in the human brain than in
the chimpanzee brain. Analyses of these promoters again
demonstrate patterns of functional enrichment and disease
association similar to the above results (Tables S6 and S7).460 The American Journal of Human Genetics 91, 455–465, SeptembDNAMethylation and Gene Expression in the Human
and Chimpanzee Brains
A well-known consequence of DNA methylation is its
effect on the regulation of gene expression.36,39 Further-
more, differential expression of genes in humans and
chimpanzees might drive lineage-specific patterns of
evolution.15,40,41 Given the profound influence of
promoter DNA methylation on the regulation of gene
expression, we asked whether changes of DNA methyla-
tion might underlie gene-expression divergence between
human and chimpanzee brains. To address this question,
we integrated data on DNA methylation with data on
gene expression from the human and chimpanzee
prefrontal cortex; these latter data were generated with a
next-generation sequencing method, digital gene-expres-
sion profiling (DGEP [Material and Methods]).
Levels of DNA methylation from promoters and gene
bodies are each significantly negatively correlated with
levels of gene expression (Spearman’s correlation coeffi-
cients range between 0.18 and approximately 0.24, as
shown in Figure 4). Several recent studies demonstrated a
‘‘bell shape’’ relationship between gene expression and
methylation—the most heavily methylated gene bodies
are often expressed at intermediate levels, and genes ex-
pressed at high and low levels are moderately methyl-
ated.11,12 However, in the prefrontal cortex samples,
gene-body methylation decreases roughly linearly with
increasing levels of gene expression in both species
(Figures 4B and 4D). This finding is similar to a recent study
in which a linear and negative relationship between gene
expression and DNA methylation in the brain (both the
occipital lobe and whole brain) was reported.39 Thus, the
effect of gene-body DNA methylation on gene expression
is not universal across different tissues.39
Among the genes whose promoters are hypomethylated
in the human brain but hypermethylated in the chim-
panzee brain, expression-level data are available for 273
genes. A majority of these exhibit higher expression in
the human brain than in the chimpanzee brain (168 out
of 273, p < 104, binomial test). In comparison, none ofer 7, 2012
Table 2. Disease-Associated Genes Are Enriched among Genes Whose Promoters Are Hypomethylated in the Human Brain but
Hypermethylated in the Chimpanzee Brain
Category Count Fold Enrichment Genes
Neural-tube defects 5 4.7 PDGFRA (MIM 173490), SHMT1 (MIM 182144), TYMS (MIM 188350), DHFR
(MIM 126060), CXCL6 (MIM 138965)
Autism 6 3.5 GABRA2 (MIM 137140), GSTM1 (MIM 138350), SLC6A4 (MIM 182138), ACCN1
(MIM 601784), CLOCK (MIM 601851), GABRG1 (MIM 137166)
Alcohol dependence 4 5.0 GABRA2 (MIM 137140), SLC6A4, GABRB1 (MIM 137190), GABRG1
Chemodependency 9 2.0 GABRA2, GSTM1, SLC6A4, GABRB1, CLOCK, SCN5A (MIM 600163), HOMER1
(MIM 604798), GABRG1, CRTC1 (MIM 607536)
Cancer 27 1.3 HPSE (MIM 604724), IRAK4 (MIM 606883), TES (MIM 606085), KIT (MIM 164920),
RECQL (MIM 600537), DHFR, KDR (MIM 191306), IKZF3 (MIM 606221), RAD51D
(MIM 602954), CDK4 (MIM 123829), CSF1 (MIM 120420), LIG3 (MIM 600940),
SUOX (MIM 606887), CXCL5 (MIM 600324), NRAS (MIM 164790), PDGFRA, GHR,
RASSF8 (MIM 608231), TYMS, POLR2B (MIM 180661), VDR (MIM 601769),
SLC6A4, GSTM1, SHMT1 (MIM 182144), STARD3 (MIM 607048), IGFBP7, POLK
(MIM 605650)
The total number of genes is 468.the three genes whose promoters are hypermethylated in
humans compared to chimpanzees exhibit increased
expression in humans. When we restrict our analyses to
genes with expression patterns that are significantly
different between human and chimpanzee brains
(Bayesian t test, p < 0.05),42 the same pattern is observed:
41 out of 58 genes with significantly hypomethylated
promoters in humans compared to chimpanzees exhibit
higher levels of expression in humans (p < 104). Thus,
differential promoter methylation between humans and
chimpanzees manifests in different transcriptional levels
(Figure 5A).
Again, we find that many of these genes are implicated
in neurological functions and disorders (Figure 5B). For
example, insulin-like growth-factor binding protein 7
(IGFBP7 [MIM 602867]) regulates insulin-like growth-
factor availability and receptor binding and is implicated
in the extinction of fear memories and neurogenesis.43
Methylation levels of IGFBP7 promoters are dramatically
different between the human and chimpanzee brains,
and the expression of this gene exhibits a pattern concor-
dant with the methylation pattern (Figure 5). In another
example, the sodium channel, voltage gated, type VIII
alpha subunit (SCN8A [MIM 600702]) is implicated in
wide-ranging neurological and behavioral disorders and
cognitive impairment44,45 and is also hypomethylated
and significantly more strongly expressed in the human
brain than in the chimpanzee brain (Figure 5).Discussion
Recent technical advances have enabled us to examine
genomic variation of DNA methylation at the nucleotide
level,18–20 allowing us to see highly complex and dynamic
tissue- and cell-type-specific patterns of genomic DNA
methylation. In parallel, new functional studies are illumi-
nating multifaceted connections between DNA methyla-The Americantion and regulation of gene expression. In addition to
being involved in the well-known effect of promoter
methylation in silencing gene expression,36 DNA methyl-
ation is also implicated in the regulation of alternative
splicing16,17 and the regulation of miRNA.46 Thus, DNA
methylation harbors a strong potential to influence regula-
tory divergence between species.
To elucidate the evolutionary significance of DNA
methylation, in this study we examined the differences
in genome-wide DNA-methylation maps of human and
chimpanzee brains and their consequences on gene-
expression divergence. A few studies have previously
investigated methylation difference between humans
and nonhuman primates, but these studies either exam-
ined an extremely limited number of sites or used methods
that are low resolution and potentially biased because of
underlying sequence differences.34,47,48 In contrast, we
used the methyl-C-seq method to resolve detailed patterns
of genomic DNA methylation at individual nucleotide
resolution.
One of the advantages of the methyl-C-seq method is
that it allows us to infer methylation frequencies of indi-
vidual CpGs quantitatively.18 Our DNA-methylation
maps reveal the prefrontal cortex to be the most heavily
methylated tissue investigated so far (Figure 1). Our results
stand in contrast to the hypothesis that DNA methylation
decreases in conjunction with cellular differentiation.18
Rather, our study suggests that DNA-methylation patterns
undergo dynamic reprogramming in a tissue- and cell-
type-specific manner. The striking enrichment of DNA
methylation in the brain (Figure 1) also has important
evolutionary implications. It has been shown repeatedly
that genes expressed in the brain are, on average, the
most evolutionarily constrained in terms of both sequence
evolution and gene–expression patterns.41,49 The observa-
tion that the brain is the most heavily methylated among
the tissues investigated so far suggests that DNA methyla-
tion might contribute to the constraints on sequence andJournal of Human Genetics 91, 455–465, September 7, 2012 461
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Figure 5. Differences in Promoter Methylation Are Associated
with Differences in Gene Expression between the Human and
Chimpanzee Prefrontal Cortex
(A) The proportion of genes with higher or lower expression values
in humans, as compared to chimpanzees, in the prefrontal cortex.
Each bar represents a class of genes and is based on the number of
standard deviations from the mean of methylation measures in
human versus chimpanzee promoters in the prefrontal cortex.
(B) Selected genes with hypomethylated promoters in humans,
hypermethylated promoters in chimpanzees, and significantly
higher expression in humans than in chimpanzees. Error bars
represent 95% confidence intervals of the mean (n ¼ 6).
Gamma-aminobutyric acid (GABA) A receptor, beta 1 (GABRB1
[MIM 137190]) is involved in neurotransmission of the CNS.
Clock homolog (mouse) (CLOCK [MIM 601851]) encodes a tran-
scription factor essential to the circadian rhythm. SCN8A facili-
tates the generation of action potentials in neurons and other
cells. Growth hormone receptor (GHR [MIM 600946]) is integral
to activating insulin-like growth-factor production, leading to
growth. IGFBP7 regulates insulin-like growth-factor availability
and receptor binding.
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Figure 4. DNAMethylation Is Negatively Correlated with Gene-
Expression Level in Both Promoters and Gene Bodies in the
Prefrontal Cortex
Integrating levels of DNA methylation with levels of gene expres-
sion measured by digital gene-expression profiling, we observe
a negative correlation between human gene-expression level and
both (A) human promoter methylation (Spearman’s correlation
coefficient r ¼ 0.24, p < 1015) and (B) human gene-body
methylation (r ¼ 0.18, p < 1015). The x axis represents
increasing levels of gene expression from left to right. We
also observe a negative correlation between chimpanzee gene-
expression level and both (C) chimpanzee promoter methylation
(r ¼ 0.19, p < 1015) and (D) chimpanzee gene-body methyla-
tion (r ¼ 0.20, p < 1015).expression evolution possibly by suppressing gene-expres-
sion noise.13,16 Similarly, heavy methylation of transpos-
able elements in the brain might indicate particularly
strong silencing of transposable elements.32
We observed intriguing within- and between-species
variation of DNA methylation in the brains of humans
and chimpanzees. In both species, samples from younger
individuals (31 years old versus 47 and 48 years old in hu-
mans; 24 and 27 years old versus 43 years old in chimpan-
zees) tend to exhibit heavier DNA methylation than do
older individuals (Figure 2). Previous studies investigating
limited numbers of CpG sites or genes reported both
increases and decreases of DNA methylation with
aging.33,50–53 Our data, although representing genome-
wide analyses of CpG sites, consist of only three individ-
uals with relatively similar ages per species and thus should
be considered with caution. Nevertheless, it is interesting
to note that studies analyzing CpG islands have generally
reported increased DNA methylation with increasing
age,33,53 whereas other studies reported that CpGs that
are not in a CpG-island context tend to lose DNA methyl-
ation with aging.52
The overall patterns of DNA methylation differ between
human and chimpanzee brains: notably, the chimpanzee462 The American Journal of Human Genetics 91, 455–465, Septembbrains exhibited higher DNA methylation levels than did
human brains. Our results are in accord with an earlier
study that used HPLC to quantify the levels of methylcyto-
sines from the brains of humans, macaques, African green
monkeys, and squirrel monkeys and showed that the
human brain exhibited the least amount of methylcyto-
sines among these species.47 However, the facts that DNAer 7, 2012
methylation varies with age and that it is not straight-
forward to ‘‘match’’ ages between human and chimpanzee
samples caution against drawing a general conclusion
from the limited number of samples used in this
study. Nevertheless, it is notable that the species-level
difference between humans and chimpanzees is the most
pronounced in promoters (Figure 3 and Figure S2). Given
the observation that human promoters are generally hypo-
methylated when compared to chimpanzee promoters, the
increase of gene expression in the human brains compared
to the brains of chimpanzees54–56 might be partially medi-
ated by an overall decrease of DNA methylation, particu-
larly in promoters. Future analyses of outgroup primates,
such as Old World monkeys, will help elucidate lineage-
specific changes in these epigenetic modifications.
Furthermore, promoters that are significantly differen-
tially methylated between the brains of humans and chim-
panzees (most of these promoters are hypomethylated in
human brains compared to chimpanzee brains) are en-
riched in several functional categories, including protein
binding and cellular metabolic processes. Strikingly, the
list of genes harboring differentially methylated promoters
includes disproportionately high numbers of those associ-
ated with human diseases (Table 2). In particular, this list of
disease includes neurodevelopmental and psychological
disorders, such as neural-tube defects, autism, and alcohol
and other chemical dependencies. Interestingly, they rep-
resent a characteristic set of diseases to which modern
humans are particularly susceptible.57 This suggests that
methylation differences between human and chimpanzee
brains might have significant functional consequences
and potentially bear relevance to the evolution of
human-specific disease vulnerabilities. Given that DNA
methylation functions as a modulator of environmental
signals to cellular regulatorymachineries,58,59 comparative
epigenomic studies like ours will allow us to better under-
stand both the genetic and environmental contributions
to species differences. Thus, our results highlight the utility
of comparative studies in identifying key epigenomic
modifications underlying human-specific phenotypes,
including disease vulnerabilities.Supplemental Data
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